Úc - Tiếng Anh - APVMA (Australian Pesticides and Veterinary Medicines Authority)

diversey australia pty. limited - ethoxylated lanolin; sorbitol; propylene glycol - topical solution/suspension - ethoxylated lanolin ungrouped active 3.0 g/l; sorbitol carbohydrate active 600.0 g/l; propylene glycol solvent active 200.0 g/l - dermatological preps. - dairy cattle | bovine | breeders | calves | dairy cow | growers | lactating cow | milking cow - enhance teat condition

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - lanolin 2.611%{relative} equivalent to 3% w/w; light liquid paraffin 79.9744%{relative} equivalent to 91.9% w/w - bath oil - active: lanolin 2.611%{relative} equivalent to 3% w/w light liquid paraffin 79.9744%{relative} equivalent to 91.9% w/w excipient: oxybenzone polyethylene glycol 400 dilaurate

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - lanolin 0.6%; light liquid paraffin 15.9% - lotion - active: lanolin 0.6% light liquid paraffin 15.9% excipient: carbomer docusate sodium glyceryl 1-monostearate lauromacrogol 200 macrogol stearate 2000 methyl hydroxybenzoate polyethylene glycol 400 dilaurate propyl hydroxybenzoate propylene glycol purified water trolamine

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

crackerjack investments ltd - allyl isothiocyanate 1.2%; eucalyptus oil 2.35%; menthol 7.5%; methyl salicylate 36.6% - topical ointment - active: allyl isothiocyanate 1.2% eucalyptus oil 2.35% menthol 7.5% methyl salicylate 36.6%

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - lanolin 3%; light liquid paraffin 91% - bath oil - 3%/91% - active: lanolin 3% light liquid paraffin 91%

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

savage laboratories a division of fougera pharmaceuticals inc. - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - nitroglycerin 20 mg in 1 g - nitroglycerin ointment is indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of transdermal nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. allergic reactions to organic nitrates are extremely rare, but they do occur. nitroglycerin is contraindicated in patients who are allergic to it.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

cosette pharmaceuticals, inc. - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1.2 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hpa axis suppression and cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio. hypothalamic-pituitary-adrenal (hpa) axis suppression, cushing's syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. manifestations of adrenal suppression in children include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to acth stimulation. manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema. administration of topic

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

alcon - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - solution/ drops - 150 mg in 1 ml - for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms and as an adjunctive in systemic sulfonamide therapy of trachoma: escherichia coli, staphylococcus aureus, streptococcus pneumoniae, streptococcus ( viridans group), haemophilus influenzae, klebsiella species, and enterobacter species. for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms. topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeruginosa. a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. hypersensitivity to sulfonamides or to any ingredient of the preparation.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

alcon laboratories, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - ointment - 3.5 mg in 1 g - stratol ophthalmic ointment is indicated in the topical treatment of infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis, and keratoconjunctivitis, blepharitis and blepharoconjunctivitis, acute meibomianitis and dacryocystitis. epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella, and many other viral diseases of the cornea and conjunctiva. mycobacterial infection of the eye. fungal diseases of ocular structures. hypersensitivity to a component of the medication.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

proficient rx lp - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - neomycin 3.5 mg in 1 g - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain cases of infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drugs in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/enter